Opportunity Information: Apply for PAR 22 025
The NIDCD Clinical Research Center Grant (P50, Clinical Trial Optional), funding opportunity number PAR-22-025, is a National Institutes of Health (NIH) discretionary grant program focused on supporting clinical research centers that can meaningfully move the field forward in diagnosing, preventing, treating, and reducing the impact of human communication disorders. The opportunity is administered by the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA (Assistance Listing) 93.173, and it uses the P50 "center grant" mechanism, which is typically intended to build and sustain a coordinated, multi-project research effort rather than a single stand-alone study.
For this program, NIDCD uses a broad definition of clinical research. Projects must involve people with communication disorders or the use of data and/or tissues obtained from individuals with a communication disorder. The scientific scope spans essentially the full range of NIDCD mission areas, including disorders of hearing, balance, smell, taste, voice, speech, and language. The announcement makes clear that many kinds of clinically oriented work can fit, such as studies addressing prevention, disease mechanisms (pathogenesis and pathophysiology), diagnosis, treatment, clinical management, and epidemiology. Importantly, proposing a clinical trial is allowed but not required, so applicants can build centers around observational studies, diagnostic validation, biomarker work, natural history studies, intervention development, or full interventional trials, as long as the overall program remains grounded in human clinical research relevant to communication disorders.
Eligibility is broad and includes a wide mix of public and private organizations. Eligible applicants include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The notice also highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, it draws clear boundaries around foreign participation: non-U.S. (non-domestic) entities and non-U.S. components of U.S. organizations are not eligible to apply, though foreign components are allowed when they meet the NIH Grants Policy Statement definition (meaning a U.S. applicant can include a foreign component in the project under NIH rules, even though a foreign institution cannot be the applicant organization).
Key administrative details provided include an original closing date of 2024-10-09, and a creation date of 2021-10-07. The award ceiling and expected number of awards are not specified in the provided data, which generally means applicants need to consult the full funding announcement and NIDCD guidance (and often NIDCD program staff) for budget expectations, allowable costs, center structure requirements, and review considerations typical of P50 applications. Overall, the program is aimed at building strong, collaborative clinical research centers that can generate clinically relevant evidence and tools to improve outcomes for people with communication disorders, with flexibility to include clinical trials when they make sense for the center's goals.Apply for PAR 22 025
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173.
- This funding opportunity was created on 2021-10-07.
- Applicants must submit their applications by 2024-10-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIDCD Clinical Research Center Grant (P50, Clinical Trial Optional) - PAR-22-025
What is this funding opportunity?
This opportunity is the NIDCD Clinical Research Center Grant using the P50 center grant mechanism. It is a National Institutes of Health (NIH) discretionary grant program administered by the National Institute on Deafness and Other Communication Disorders (NIDCD). The funding opportunity number is PAR-22-025.
What is the goal of the NIDCD Clinical Research Center Grant program?
The program is intended to support clinical research centers that can meaningfully move the field forward in diagnosing, preventing, treating, and reducing the impact of human communication disorders.
Which NIH institute administers this grant?
The program is administered by the National Institute on Deafness and Other Communication Disorders (NIDCD), which is part of the National Institutes of Health (NIH).
What is the Assistance Listing (CFDA) number for this program?
The Assistance Listing (formerly CFDA) number provided for this opportunity is 93.173.
What type of grant mechanism is a P50?
P50 is a "center grant" mechanism. It is typically designed to build and sustain a coordinated, multi-project research effort rather than support a single stand-alone study.
Are clinical trials required under this opportunity?
No. Clinical trials are allowed but not required. The opportunity is described as "Clinical Trial Optional," so a center can include clinical trials when appropriate, but can also be built around other forms of clinical research.
How does NIDCD define "clinical research" for this program?
NIDCD uses a broad definition of clinical research for this program. Projects must involve people with communication disorders or the use of data and/or tissues obtained from individuals with a communication disorder.
What scientific areas are within scope for this clinical research center grant?
The scope spans the full range of NIDCD mission areas, including disorders of hearing, balance, smell, taste, voice, speech, and language.
What kinds of clinically oriented studies can fit under this program?
The announcement indicates that many types of clinically oriented work may fit, including studies addressing prevention, disease mechanisms (pathogenesis and pathophysiology), diagnosis, treatment, clinical management, and epidemiology.
Can a center application focus on observational or non-interventional clinical research?
Yes. Because clinical trials are optional, applicants may build centers around observational studies, diagnostic validation, biomarker work, natural history studies, or intervention development, as long as the overall program is grounded in human clinical research relevant to communication disorders.
What does it mean that projects must be grounded in human clinical research?
Based on the provided description, the center's projects must involve people with communication disorders or use data and/or tissues from individuals with a communication disorder, and the overall program must be relevant to improving understanding, diagnosis, prevention, treatment, or management of communication disorders.
Who is eligible to apply for this grant opportunity?
Eligibility is broad and includes many public and private organizations. Eligible applicants include state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; non-federally recognized Native American tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses.
Are any specific institution types explicitly highlighted as eligible?
Yes. The notice highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
Can foreign (non-U.S.) organizations apply as the applicant institution?
No. Non-U.S. (non-domestic) entities are not eligible to apply as the applicant organization for this opportunity.
Are non-U.S. components of U.S. organizations eligible to apply?
No. Non-U.S. components of U.S. organizations are not eligible to apply as the applicant.
Can a U.S. applicant include a foreign component in the project?
Yes. While foreign institutions cannot be the applicant organization, foreign components are allowed when they meet the NIH Grants Policy Statement definition. This means a U.S. applicant may include a foreign component under NIH rules, even though the foreign institution itself cannot submit the application as the primary applicant.
What are the key dates mentioned for this opportunity?
The provided administrative details include a creation date of 2021-10-07 and an original closing date of 2024-10-09.
Is the award ceiling provided?
No. The award ceiling is not specified in the provided information.
Is the expected number of awards provided?
No. The expected number of awards is not specified in the provided information.
What should applicants do if budget expectations and center structure requirements are not listed here?
Based on the provided description, applicants may need to consult the full funding announcement (PAR-22-025) and NIDCD guidance for budget expectations, allowable costs, center structure requirements, and review considerations typical of P50 applications, and may also consider contacting NIDCD program staff for clarification.
What is the overall program emphasis for funded centers?
The program emphasizes building strong, collaborative clinical research centers that can generate clinically relevant evidence and tools to improve outcomes for people with communication disorders, with flexibility to include clinical trials when they align with the center's goals.
Browse more opportunities from the same category: Health
Next opportunity: Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
Previous opportunity: Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 22 025
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 22 025) also looked into and applied for these:
| Funding Opportunity |
|---|
| IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) Apply for RFA GM 22 001 Funding Number: RFA GM 22 001 Agency: National Institutes of Health Category: Health Funding Amount: $252,000 |
| Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) Apply for RFA MH 22 120 Funding Number: RFA MH 22 120 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) Apply for PAR 22 034 Funding Number: PAR 22 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Apply for PAR 21 321 Funding Number: PAR 21 321 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for PAR 22 048 Funding Number: PAR 22 048 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) Apply for PAR 22 039 Funding Number: PAR 22 039 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) Apply for PAR 22 040 Funding Number: PAR 22 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) Apply for PAR 22 038 Funding Number: PAR 22 038 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 070 Funding Number: RFA AI 21 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional) Apply for RFA MH 22 105 Funding Number: RFA MH 22 105 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Digital Health Strengthening in Eswatini Apply for RFI67421ESWATINIHEALTHINFORMATIONSYSTEM Funding Number: RFI67421ESWATINIHEALTHINFORMATIONSYSTEM Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required) Apply for RFA MH 22 125 Funding Number: RFA MH 22 125 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 075 Funding Number: RFA AI 21 075 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) Apply for RFA MH 22 106 Funding Number: RFA MH 22 106 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional) Apply for RFA AG 23 001 Funding Number: RFA AG 23 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Murine Tissue Mapping Centers (U54 - Clinical Trial Not Allowed) Apply for RFA RM 22 003 Funding Number: RFA RM 22 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Potential New Care and Treatment (C&T) Health Activity. Apply for 72051722RFICT00001 Funding Number: 72051722RFICT00001 Agency: Dominican Republic USAID-Santo Domingo Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 22 005 Funding Number: RFA RM 22 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) Apply for RFA AG 23 002 Funding Number: RFA AG 23 002 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 22 004 Funding Number: RFA RM 22 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 025", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.